The global Oncology Immunotherapy market was valued at US$ 2251 million in 2023 and is anticipated to reach US$ 3807.5 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.

Oncology Immunotherapy Market

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

The Oncology Immunotherapy market has expanded as a groundbreaking approach to treating cancer by harnessing the body's immune system to target and fight cancer cells. This innovative therapy includes immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines, among others. By enhancing the immune response against tumors, immunotherapy offers potentially durable and targeted treatments, often with fewer side effects compared to traditional approaches. The market's growth is driven by promising clinical outcomes and a growing understanding of immune-tumor interactions. As researchers continue to explore and refine immunotherapeutic strategies, the Oncology Immunotherapy market remains at the forefront of oncology, revolutionizing cancer treatment paradigms and offering new hope to patients.

This report aims to provide a comprehensive presentation of the global market for Oncology Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Immunotherapy.

Report Scope

The Oncology Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oncology Immunotherapy Market Report

Report Metric	Details
Report Name	Oncology Immunotherapy Market
Accounted market size in 2023	US$ 2251 million
Forecasted market size in 2030	US$ 3807.5 million
CAGR	8.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Immune Checkpoint Inhibitors Cytokine-Based Immunotherapy Cancer Vaccines CAR-T Cell Therapy Other
Segment by Application	Hospitals Drugstores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, Merck & Co, Roche AG, AstraZeneca, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oncology Immunotherapy Market growing?

Ans: The Oncology Immunotherapy Market witnessing a CAGR of 8.3% during the forecast period 2024-2030.

What is the Oncology Immunotherapy Market size in 2030?

Ans: The Oncology Immunotherapy Market size in 2030 will be US$ 3807.5 million.

Who are the main players in the Oncology Immunotherapy Market report?

Ans: The main players in the Oncology Immunotherapy Market are Bristol-Myers Squibb, Merck & Co, Roche AG, AstraZeneca, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA

What are the Application segmentation covered in the Oncology Immunotherapy Market report?

Ans: The Applications covered in the Oncology Immunotherapy Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Oncology Immunotherapy Market report?

Ans: The Types covered in the Oncology Immunotherapy Market report are Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncology Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Immune Checkpoint Inhibitors

1.2.3 Cytokine-Based Immunotherapy

1.2.4 Cancer Vaccines

1.2.5 CAR-T Cell Therapy

1.2.6 Other

1.3 Market by Application

1.3.1 Global Oncology Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncology Immunotherapy Market Perspective (2019-2030)

2.2 Oncology Immunotherapy Growth Trends by Region

2.2.1 Global Oncology Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Oncology Immunotherapy Historic Market Size by Region (2019-2024)

2.2.3 Oncology Immunotherapy Forecasted Market Size by Region (2025-2030)

2.3 Oncology Immunotherapy Market Dynamics

2.3.1 Oncology Immunotherapy Industry Trends

2.3.2 Oncology Immunotherapy Market Drivers

2.3.3 Oncology Immunotherapy Market Challenges

2.3.4 Oncology Immunotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncology Immunotherapy Players by Revenue

3.1.1 Global Top Oncology Immunotherapy Players by Revenue (2019-2024)

3.1.2 Global Oncology Immunotherapy Revenue Market Share by Players (2019-2024)

3.2 Global Oncology Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Oncology Immunotherapy Revenue

3.4 Global Oncology Immunotherapy Market Concentration Ratio

3.4.1 Global Oncology Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncology Immunotherapy Revenue in 2023

3.5 Oncology Immunotherapy Key Players Head office and Area Served

3.6 Key Players Oncology Immunotherapy Product Solution and Service

3.7 Date of Enter into Oncology Immunotherapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Immunotherapy Breakdown Data by Type

4.1 Global Oncology Immunotherapy Historic Market Size by Type (2019-2024)

4.2 Global Oncology Immunotherapy Forecasted Market Size by Type (2025-2030)

5 Oncology Immunotherapy Breakdown Data by Application

5.1 Global Oncology Immunotherapy Historic Market Size by Application (2019-2024)

5.2 Global Oncology Immunotherapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Oncology Immunotherapy Market Size (2019-2030)

6.2 North America Oncology Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Oncology Immunotherapy Market Size by Country (2019-2024)

6.4 North America Oncology Immunotherapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncology Immunotherapy Market Size (2019-2030)

7.2 Europe Oncology Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Oncology Immunotherapy Market Size by Country (2019-2024)

7.4 Europe Oncology Immunotherapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oncology Immunotherapy Market Size (2019-2030)

8.2 Asia-Pacific Oncology Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Oncology Immunotherapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Oncology Immunotherapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oncology Immunotherapy Market Size (2019-2030)

9.2 Latin America Oncology Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Oncology Immunotherapy Market Size by Country (2019-2024)

9.4 Latin America Oncology Immunotherapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncology Immunotherapy Market Size (2019-2030)

10.2 Middle East & Africa Oncology Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Oncology Immunotherapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Oncology Immunotherapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Company Detail

11.1.2 Bristol-Myers Squibb Business Overview

11.1.3 Bristol-Myers Squibb Oncology Immunotherapy Introduction

11.1.4 Bristol-Myers Squibb Revenue in Oncology Immunotherapy Business (2019-2024)

11.1.5 Bristol-Myers Squibb Recent Development

11.2 Merck & Co

11.2.1 Merck & Co Company Detail

11.2.2 Merck & Co Business Overview

11.2.3 Merck & Co Oncology Immunotherapy Introduction

11.2.4 Merck & Co Revenue in Oncology Immunotherapy Business (2019-2024)

11.2.5 Merck & Co Recent Development

11.3 Roche AG

11.3.1 Roche AG Company Detail

11.3.2 Roche AG Business Overview

11.3.3 Roche AG Oncology Immunotherapy Introduction

11.3.4 Roche AG Revenue in Oncology Immunotherapy Business (2019-2024)

11.3.5 Roche AG Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Detail

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Oncology Immunotherapy Introduction

11.4.4 AstraZeneca Revenue in Oncology Immunotherapy Business (2019-2024)

11.4.5 AstraZeneca Recent Development

11.5 Sanofi S.A.

11.5.1 Sanofi S.A. Company Detail

11.5.2 Sanofi S.A. Business Overview

11.5.3 Sanofi S.A. Oncology Immunotherapy Introduction

11.5.4 Sanofi S.A. Revenue in Oncology Immunotherapy Business (2019-2024)

11.5.5 Sanofi S.A. Recent Development

11.6 Dendreon Pharmaceuticals

11.6.1 Dendreon Pharmaceuticals Company Detail

11.6.2 Dendreon Pharmaceuticals Business Overview

11.6.3 Dendreon Pharmaceuticals Oncology Immunotherapy Introduction

11.6.4 Dendreon Pharmaceuticals Revenue in Oncology Immunotherapy Business (2019-2024)

11.6.5 Dendreon Pharmaceuticals Recent Development

11.7 Novartis

11.7.1 Novartis Company Detail

11.7.2 Novartis Business Overview

11.7.3 Novartis Oncology Immunotherapy Introduction

11.7.4 Novartis Revenue in Oncology Immunotherapy Business (2019-2024)

11.7.5 Novartis Recent Development

11.8 Gilead Sciences Inc.

11.8.1 Gilead Sciences Inc. Company Detail

11.8.2 Gilead Sciences Inc. Business Overview

11.8.3 Gilead Sciences Inc. Oncology Immunotherapy Introduction

11.8.4 Gilead Sciences Inc. Revenue in Oncology Immunotherapy Business (2019-2024)

11.8.5 Gilead Sciences Inc. Recent Development

11.9 Merck KGaA

11.9.1 Merck KGaA Company Detail

11.9.2 Merck KGaA Business Overview

11.9.3 Merck KGaA Oncology Immunotherapy Introduction

11.9.4 Merck KGaA Revenue in Oncology Immunotherapy Business (2019-2024)

11.9.5 Merck KGaA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc

Merck KGaA

List of Tables

Table 1. Global Oncology Immunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Immune Checkpoint Inhibitors

Table 3. Key Players of Cytokine-Based Immunotherapy

Table 4. Key Players of Cancer Vaccines

Table 5. Key Players of CAR-T Cell Therapy

Table 6. Key Players of Other

Table 7. Global Oncology Immunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Oncology Immunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Oncology Immunotherapy Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Oncology Immunotherapy Market Share by Region (2019-2024)

Table 11. Global Oncology Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Oncology Immunotherapy Market Share by Region (2025-2030)

Table 13. Oncology Immunotherapy Market Trends

Table 14. Oncology Immunotherapy Market Drivers

Table 15. Oncology Immunotherapy Market Challenges

Table 16. Oncology Immunotherapy Market Restraints

Table 17. Global Oncology Immunotherapy Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Oncology Immunotherapy Market Share by Players (2019-2024)

Table 19. Global Top Oncology Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Immunotherapy as of 2023)

Table 20. Ranking of Global Top Oncology Immunotherapy Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Oncology Immunotherapy Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Oncology Immunotherapy Product Solution and Service

Table 24. Date of Enter into Oncology Immunotherapy Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Oncology Immunotherapy Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Oncology Immunotherapy Revenue Market Share by Type (2019-2024)

Table 28. Global Oncology Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Oncology Immunotherapy Revenue Market Share by Type (2025-2030)

Table 30. Global Oncology Immunotherapy Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Oncology Immunotherapy Revenue Market Share by Application (2019-2024)

Table 32. Global Oncology Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Oncology Immunotherapy Revenue Market Share by Application (2025-2030)

Table 34. North America Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Oncology Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Oncology Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Oncology Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Oncology Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Oncology Immunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Oncology Immunotherapy Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Oncology Immunotherapy Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Oncology Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Oncology Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Oncology Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Oncology Immunotherapy Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Oncology Immunotherapy Market Size by Country (2025-2030) & (US$ Million)

Table 49. Bristol-Myers Squibb Company Detail

Table 50. Bristol-Myers Squibb Business Overview

Table 51. Bristol-Myers Squibb Oncology Immunotherapy Product

Table 52. Bristol-Myers Squibb Revenue in Oncology Immunotherapy Business (2019-2024) & (US$ Million)

Table 53. Bristol-Myers Squibb Recent Development

Table 54. Merck & Co Company Detail

Table 55. Merck & Co Business Overview

Table 56. Merck & Co Oncology Immunotherapy Product

Table 57. Merck & Co Revenue in Oncology Immunotherapy Business (2019-2024) & (US$ Million)

Table 58. Merck & Co Recent Development

Table 59. Roche AG Company Detail

Table 60. Roche AG Business Overview

Table 61. Roche AG Oncology Immunotherapy Product

Table 62. Roche AG Revenue in Oncology Immunotherapy Business (2019-2024) & (US$ Million)

Table 63. Roche AG Recent Development

Table 64. AstraZeneca Company Detail

Table 65. AstraZeneca Business Overview

Table 66. AstraZeneca Oncology Immunotherapy Product

Table 67. AstraZeneca Revenue in Oncology Immunotherapy Business (2019-2024) & (US$ Million)

Table 68. AstraZeneca Recent Development

Table 69. Sanofi S.A. Company Detail

Table 70. Sanofi S.A. Business Overview

Table 71. Sanofi S.A. Oncology Immunotherapy Product

Table 72. Sanofi S.A. Revenue in Oncology Immunotherapy Business (2019-2024) & (US$ Million)

Table 73. Sanofi S.A. Recent Development

Table 74. Dendreon Pharmaceuticals Company Detail

Table 75. Dendreon Pharmaceuticals Business Overview

Table 76. Dendreon Pharmaceuticals Oncology Immunotherapy Product

Table 77. Dendreon Pharmaceuticals Revenue in Oncology Immunotherapy Business (2019-2024) & (US$ Million)

Table 78. Dendreon Pharmaceuticals Recent Development

Table 79. Novartis Company Detail

Table 80. Novartis Business Overview

Table 81. Novartis Oncology Immunotherapy Product

Table 82. Novartis Revenue in Oncology Immunotherapy Business (2019-2024) & (US$ Million)

Table 83. Novartis Recent Development

Table 84. Gilead Sciences Inc. Company Detail

Table 85. Gilead Sciences Inc. Business Overview

Table 86. Gilead Sciences Inc. Oncology Immunotherapy Product

Table 87. Gilead Sciences Inc. Revenue in Oncology Immunotherapy Business (2019-2024) & (US$ Million)

Table 88. Gilead Sciences Inc. Recent Development

Table 89. Merck KGaA Company Detail

Table 90. Merck KGaA Business Overview

Table 91. Merck KGaA Oncology Immunotherapy Product

Table 92. Merck KGaA Revenue in Oncology Immunotherapy Business (2019-2024) & (US$ Million)

Table 93. Merck KGaA Recent Development

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oncology Immunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Oncology Immunotherapy Market Share by Type: 2023 VS 2030

Figure 3. Immune Checkpoint Inhibitors Features

Figure 4. Cytokine-Based Immunotherapy Features

Figure 5. Cancer Vaccines Features

Figure 6. CAR-T Cell Therapy Features

Figure 7. Other Features

Figure 8. Global Oncology Immunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Oncology Immunotherapy Market Share by Application: 2023 VS 2030

Figure 10. Hospitals Case Studies

Figure 11. Drugstores Case Studies

Figure 12. Others Case Studies

Figure 13. Oncology Immunotherapy Report Years Considered

Figure 14. Global Oncology Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Oncology Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Oncology Immunotherapy Market Share by Region: 2023 VS 2030

Figure 17. Global Oncology Immunotherapy Market Share by Players in 2023

Figure 18. Global Top Oncology Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Immunotherapy as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Oncology Immunotherapy Revenue in 2023

Figure 20. North America Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Oncology Immunotherapy Market Share by Country (2019-2030)

Figure 22. United States Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Oncology Immunotherapy Market Share by Country (2019-2030)

Figure 26. Germany Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Oncology Immunotherapy Market Share by Region (2019-2030)

Figure 34. China Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Oncology Immunotherapy Market Share by Country (2019-2030)

Figure 42. Mexico Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Oncology Immunotherapy Market Share by Country (2019-2030)

Figure 46. Turkey Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Oncology Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Oncology Immunotherapy Business (2019-2024)

Figure 49. Merck & Co Revenue Growth Rate in Oncology Immunotherapy Business (2019-2024)

Figure 50. Roche AG Revenue Growth Rate in Oncology Immunotherapy Business (2019-2024)

Figure 51. AstraZeneca Revenue Growth Rate in Oncology Immunotherapy Business (2019-2024)

Figure 52. Sanofi S.A. Revenue Growth Rate in Oncology Immunotherapy Business (2019-2024)

Figure 53. Dendreon Pharmaceuticals Revenue Growth Rate in Oncology Immunotherapy Business (2019-2024)

Figure 54. Novartis Revenue Growth Rate in Oncology Immunotherapy Business (2019-2024)

Figure 55. Gilead Sciences Inc. Revenue Growth Rate in Oncology Immunotherapy Business (2019-2024)

Figure 56. Merck KGaA Revenue Growth Rate in Oncology Immunotherapy Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

RELATED REPORTS

Global Pediatric Cardiac Tumor Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G6046

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Interventional Oncology Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20U7613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions